We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, Court Clear Way for Teva's, Ranbaxy's Generic Zocor
FDA, Court Clear Way for Teva's, Ranbaxy's Generic Zocor
June 27, 2006
The FDA and a federal district court have removed all obstacles for Teva and Ranbaxy to begin marketing their generic versions of Merck’s $4.4 billion cholesterol drug Zocor, the drugmakers said June 23, the day Merck’s patent expired.